We provide a portfolio of models for efficacy pharmacology in autoimmunity, immuno-oncology, and transplantation. Our humanized mouse and tumor xenograft platforms enable translational evaluation of biologics, cell therapies, and innovative immunotherapies.
Products, services, technology
Preclina's efficacy pharmacology service encompasses intractable autoimmune diseases and inflammatory disease. Moreover, our Humanized mouse platform facilitates the development of biological therapeutics in the domains of immuno-oncology and GvHD.
Cooperation possibilities
Preclina focuses on presenting non-clinical immunology services to pharma and biotech worldwide. We deliver innovative efficacy evaluation for immunological disorders and provide comprehensive assessments using humanized mice in the immuno-oncology field.
- http://www.preclina.com
- +82 10 2556 0536
- Send an email
- Young Mo Kang
